Enfermedades retinianas y nuevas terapias
University Hospital Aachen
Aachen, AlemaniaPublicaciones en colaboración con investigadores/as de University Hospital Aachen (4)
2019
-
Preclinical Evaluation of a Cell-Based Gene Therapy Using the Sleeping Beauty Transposon System in Choroidal Neovascularization
Molecular Therapy - Methods and Clinical Development, Vol. 15, pp. 403-417
2017
-
Long-Term PEDF Release in Rat Iris and Retinal Epithelial Cells after Sleeping Beauty Transposon-Mediated Gene Delivery
Molecular Therapy - Nucleic Acids, Vol. 9, pp. 1-11
2015
-
Transposon-based, targeted ex vivo gene therapy to treat age-related macular degeneration (TargetAMD)
Human Gene Therapy Clinical Development, Vol. 26, Núm. 2, pp. 97-100
2014
-
Current treatment limitations in age-related macular degeneration and future approaches based on cell therapy and tissue engineering
Journal of Ophthalmology, Vol. 2014